Your kidneys aren’t just filters—they’re also hormone hubs that help control blood pressure, calcium, and bone health. Hormones like parathyroid hormone, calcitonin, and those in the renin–angiotensin ...

COPENHAGEN, Denmark, May 13, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced 2-year results from a post-hoc analysis of the Company’s Phase 3 PaTHway Trial demonstrating ...

Impaired coronary flow reserve in patients with metastatic cancer treated with sunitinib. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Palopegteriparatide improved skeletal dynamics and renal ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...

COPENHAGEN, Denmark, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced that a new pooled analysis showed sustained and clinically meaningful improvements in renal function ...

Dawn Ethier, a police officer in Ottawa, Canada, recalls how her life revolved around managing her 100-pill-a-day regimen. Her symptoms began 3 weeks after her thyroid surgery, but it took another 4 ...

The well conceived clinical study of Barreras and Donaldson reported elsewhere in this issue of the Journal indicates clearly that gastric hypersecretion in a given patient can accompany long-term ...

Results showed eneboparatide compared with placebo met the primary endpoint with statistical significance at 24 weeks. Topline data were announced from a phase 3 trial evaluating eneboparatide in ...